Completed OBSERVATIONAL NCT02345473

Detection and Clinical Significance of Circulating Cancer Cells in Patient Undergoing Radical Cystectomy (CirCanCell)

Sponsor: Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari

Conditions Bladder Cancer Circulating Tumor Cells

Interventions Detection of circulating tumor cells in blood samples

Updated 11 times since 2017 Last updated: Jan 19, 2015 Started: Jan 31, 2005 Primary completion: Oct 31, 2014 Completion: Oct 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Bladder Cancer and Circulating Tumor Cells, this trial is completed. The trial is conducted by Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari and has accumulated 11 data snapshots since 2005. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

11 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2021 — Jul 2024 [monthly]

Completed
Jan 2021 — Dec 2021 [monthly]

Completed
Dec 2020 — Jan 2021 [monthly]

Completed

▶ Show 6 earlier versions

Nov 2020 — Dec 2020 [monthly]

Completed
Jun 2018 — Nov 2020 [monthly]

Completed
May 2018 — Jun 2018 [monthly]

Completed
Apr 2018 — May 2018 [monthly]

Completed

Phase: NA → None
Aug 2017 — Apr 2018 [monthly]

Completed NA
Jan 2017 — Aug 2017 [monthly]

Completed NA

First recorded

Jan 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari

Data source: Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bari, Italy